Samsung Pharm (001360) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, Samsung Pharm (001360) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.29 Billion ≈ $-1.55 Million USD) by net assets (₩180.09 Billion ≈ $122.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 001360 stock market capitalisation for the company's overall valuation and market capitalisation.

Samsung Pharm - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Samsung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Samsung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Samsung Pharm ranked by their cash flow conversion efficiency. Explore 001360 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ATM Grupa S.A. WAR:ATG	0.012x
TVS Electronics Limited NSE:TVSELECT	-0.125x
Berenson Acquisition Corp I NYSE MKT:BACA	1.396x
Finder Energy Holdings Ltd AU:FDR	-0.630x
HLB Life Science Co. Ltd KQ:067630	-0.016x
True North Commercial Real Estate Investment Trust TO:TNT-UN	0.042x
MaxCyte Inc NASDAQ:MXCT	-0.041x
Centrica PLC LSE:CNA	0.012x

Annual Cash Flow Conversion Efficiency for Samsung Pharm (2012–2024)

The table below shows the annual cash flow conversion efficiency of Samsung Pharm from 2012 to 2024. View 001360 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩105.86 Billion ≈ $71.74 Million	₩-17.30 Billion ≈ $-11.72 Million	-0.163x	+54.17%
2023-12-31	₩77.58 Billion ≈ $52.58 Million	₩-27.66 Billion ≈ $-18.74 Million	-0.356x	-1810.44%
2022-12-31	₩102.59 Billion ≈ $69.52 Million	₩-1.91 Billion ≈ $-1.30 Million	-0.019x	+66.85%
2021-12-31	₩127.27 Billion ≈ $86.25 Million	₩-7.16 Billion ≈ $-4.85 Million	-0.056x	-168.73%
2020-12-31	₩121.92 Billion ≈ $82.62 Million	₩-2.55 Billion ≈ $-1.73 Million	-0.021x	-22.88%
2019-12-31	₩142.83 Billion ≈ $96.79 Million	₩-2.43 Billion ≈ $-1.65 Million	-0.017x	+65.59%
2018-12-31	₩131.66 Billion ≈ $89.23 Million	₩-6.52 Billion ≈ $-4.42 Million	-0.050x	-190.23%
2017-12-31	₩93.87 Billion ≈ $63.61 Million	₩5.15 Billion ≈ $3.49 Million	0.055x	+145.48%
2016-12-31	₩82.38 Billion ≈ $55.83 Million	₩-9.94 Billion ≈ $-6.74 Million	-0.121x	-32.70%
2015-12-31	₩46.24 Billion ≈ $31.33 Million	₩-4.20 Billion ≈ $-2.85 Million	-0.091x	+84.40%
2014-12-31	₩23.29 Billion ≈ $15.79 Million	₩-13.58 Billion ≈ $-9.21 Million	-0.583x	-81.92%
2012-12-31	₩34.71 Billion ≈ $23.52 Million	₩-11.13 Billion ≈ $-7.54 Million	-0.321x	--

About Samsung Pharm

KO:001360 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$84.45 Million

₩124.62 Billion KRW

Market Cap Rank

#19950 Global

#1043 in Korea

Share Price

₩1324.00

Change (1 day)

+0.38%

52-Week Range

₩1180.00 - ₩2210.00

All Time High

₩12289.83